![Cureus | Analysis of Overall Survival in Patients With Multiple Primary Malignancies: A Single-center Experience Cureus | Analysis of Overall Survival in Patients With Multiple Primary Malignancies: A Single-center Experience](https://assets.cureus.com/uploads/figure/file/56884/lightbox_96799eb01b4f11e9836e8ffceb76b5f5-Figure-1.png)
Cureus | Analysis of Overall Survival in Patients With Multiple Primary Malignancies: A Single-center Experience
![Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study | Leukemia Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study | Leukemia](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41375-020-01042-y/MediaObjects/41375_2020_1042_Fig2_HTML.png)
Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study | Leukemia
PLOS ONE: Unbiased and Automated Identification of a Circulating Tumour Cell Definition That Associates with Overall Survival
![Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: An individual patient pooled analysis of 10 European Organisation for Research and Treatment of Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: An individual patient pooled analysis of 10 European Organisation for Research and Treatment of](https://ars.els-cdn.com/content/image/1-s2.0-S0959804914008727-gr1.jpg)
Progression free survival rate at 9 and 18 weeks predict overall survival in patients with malignant pleural mesothelioma: An individual patient pooled analysis of 10 European Organisation for Research and Treatment of
![Kaplan-Meier overall survival (OS) functions are illustrated. Patients... | Download Scientific Diagram Kaplan-Meier overall survival (OS) functions are illustrated. Patients... | Download Scientific Diagram](https://www.researchgate.net/profile/Jochen-Lorch/publication/51727572/figure/fig1/AS:277568352735235@1443188860176/Kaplan-Meier-overall-survival-OS-functions-are-illustrated-Patients-are-grouped-based.png)
Kaplan-Meier overall survival (OS) functions are illustrated. Patients... | Download Scientific Diagram
![Clinically meaningful benefit: real world use compared against the American and European guidelines | Blood Cancer Journal Clinically meaningful benefit: real world use compared against the American and European guidelines | Blood Cancer Journal](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41408-017-0009-8/MediaObjects/41408_2017_9_Fig1_HTML.gif)
Clinically meaningful benefit: real world use compared against the American and European guidelines | Blood Cancer Journal
![The figure shows progression-free survival (PFS) and overall survival... | Download Scientific Diagram The figure shows progression-free survival (PFS) and overall survival... | Download Scientific Diagram](https://www.researchgate.net/profile/Keisuke-Eguchi/publication/231863562/figure/fig1/AS:282062016794649@1444260233265/The-figure-shows-progression-free-survival-PFS-and-overall-survival-OS-from-the-start.png)
The figure shows progression-free survival (PFS) and overall survival... | Download Scientific Diagram
![Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study | BMC Medicine | Full Text Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study | BMC Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12916-018-1120-9/MediaObjects/12916_2018_1120_Fig1_HTML.png)
Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study | BMC Medicine | Full Text
![Frontiers | Analysis of Survival Curves: Statistical Methods Accounting for the Presence of Long-Term Survivors | Oncology Frontiers | Analysis of Survival Curves: Statistical Methods Accounting for the Presence of Long-Term Survivors | Oncology](https://www.frontiersin.org/files/Articles/464476/fonc-09-00453-HTML/image_m/fonc-09-00453-g001.jpg)
Frontiers | Analysis of Survival Curves: Statistical Methods Accounting for the Presence of Long-Term Survivors | Oncology
![Social determinants of health and survival on Brazilian patients with glioblastoma: a retrospective analysis of a large populational database - The Lancet Regional Health – Americas Social determinants of health and survival on Brazilian patients with glioblastoma: a retrospective analysis of a large populational database - The Lancet Regional Health – Americas](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/d3f9dc49-a23b-4a1e-acbe-628abb1d7af8/gr1.jpg)
Social determinants of health and survival on Brazilian patients with glioblastoma: a retrospective analysis of a large populational database - The Lancet Regional Health – Americas
![Definition of progression free survival and overall survival for the... | Download Scientific Diagram Definition of progression free survival and overall survival for the... | Download Scientific Diagram](https://www.researchgate.net/publication/265644752/figure/fig1/AS:269802786783234@1441337405030/Definition-of-progression-free-survival-and-overall-survival-for-the-Gold-standard-and.png)
Definition of progression free survival and overall survival for the... | Download Scientific Diagram
![Overall survival curve. Median overall survival time was 8.2 months.... | Download Scientific Diagram Overall survival curve. Median overall survival time was 8.2 months.... | Download Scientific Diagram](https://www.researchgate.net/profile/Atsushi-Nashimoto/publication/5872888/figure/fig1/AS:601697068015627@1520467168720/Overall-survival-curve-Median-overall-survival-time-was-82-months-The-initial-date-of.png)
Overall survival curve. Median overall survival time was 8.2 months.... | Download Scientific Diagram
![Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001 - Annals of Oncology Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001 - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/92cdb022-7df4-45ab-861e-09c65062be4a/gr1_lrg.jpg)